U.S. Markets close in 5 hrs 36 mins
  • S&P 500

    3,686.26
    +19.54 (+0.53%)
     
  • Dow 30

    30,108.35
    +138.83 (+0.46%)
     
  • Nasdaq

    12,418.74
    +41.56 (+0.34%)
     
  • Russell 2000

    1,864.38
    +15.68 (+0.85%)
     
  • Crude Oil

    46.01
    +0.37 (+0.81%)
     
  • Gold

    1,841.40
    +0.30 (+0.02%)
     
  • Silver

    24.25
    +0.12 (+0.49%)
     
  • EUR/USD

    1.2146
    -0.0003 (-0.0243%)
     
  • 10-Yr Bond

    0.9740
    +0.0540 (+5.87%)
     
  • Vix

    20.75
    -0.53 (-2.49%)
     
  • GBP/USD

    1.3485
    +0.0033 (+0.2441%)
     
  • USD/JPY

    104.1100
    +0.2500 (+0.2407%)
     
  • BTC-USD

    19,014.93
    -242.65 (-1.26%)
     
  • CMC Crypto 200

    372.97
    -6.27 (-1.65%)
     
  • FTSE 100

    6,546.89
    +56.62 (+0.87%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Omeros: 3Q Earnings Snapshot

·1 min read

SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $38.5 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 66 cents. Losses, adjusted for one-time gains and costs, were 34 cents per share.

The drug developer posted revenue of $26.1 million in the period.

Omeros shares have dropped 22% since the beginning of the year. In the final minutes of trading on Monday, shares hit $10.99, a decrease of 19% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER